OPK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OPK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, OPKO Health's enterprise value is $1,111.7 Mil. OPKO Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $150.5 Mil. Therefore, OPKO Health's EV-to-EBITDA for today is 7.38.
The historical rank and industry rank for OPKO Health's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of OPKO Health was 3759.31. The lowest was -126.86. And the median was -9.48.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2025-05-20), OPKO Health's stock price is $1.33. OPKO Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.070. Therefore, OPKO Health's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for OPKO Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPKO Health Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial |
![]() |
![]() |
18.41 | 40.66 | -4.13 | -21.34 | 7.83 |
OPKO Health Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
EV-to-EBITDA | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-9.22 | -9.20 | 59.23 | 7.83 | 9.12 |
For the Diagnostics & Research subindustry, OPKO Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where OPKO Health's EV-to-EBITDA falls into.
OPKO Health's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 1111.650 | / | 150.534 | |
= | 7.38 |
OPKO Health's current Enterprise Value is $1,111.7 Mil.
OPKO Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $150.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OPKO Health (NAS:OPK) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
OPKO Health's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 1.33 | / | -0.070 | |
= | At Loss |
OPKO Health's share price for today is $1.33.
OPKO Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.070.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of OPKO Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Frost Phillip Md Et Al | 10 percent owner | 4400 BISCAYNE BLVD, MIAMI FL 33137-3227 |
Richard M Krasno | director | C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 31337 |
Hsiao Jane Ph D | director | 4400 BISCAYNE BLVD, MIAMI FL 33137 |
Gary J. Nabel | director, officer: Chief Innovation Officer | C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065 |
Elias A. Zerhouni | director, officer: Vice Chairman and President | 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR, WASHINGTON DC 20006 |
John A Paganelli | director, other: Chairman of the Board | OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Pfenniger Richard C Jr | director | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Steven D Rubin | director | OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Alexis Borisy | director | C/O COMBINATORX, INCORPORATED, 245 FIRST STREET, 16TH FLOOR, CAMBRIDGE MA 02142 |
Jon R Cohen | director, officer: SVP OPKO; Exec Chairman BRLI | C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Prem A Lachman | director | 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Roger Md Medel | director | 1301 CONCORD TERRACE, SUNRISE FL 33323 |
Rulfo Fernando Hernandez | officer: CAO, Treasurer | C/O OPKO HEALTH INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Anthony J Japour | director | 19805 N. CREEK PARKWAY, BOTHELL WA 98011 |
Robert Scott Fishel | director | C/O OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
From GuruFocus
By GuruFocus News • 03-04-2025
By GuruFocus News • 11-08-2024
By Marketwired • 01-09-2025
By Marketwired • 11-20-2024
By Marketwired • 08-07-2024
By GuruFocus News • 04-04-2025
By Marketwired • 03-17-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 02-28-2025
By Marketwired • 02-27-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.